ScripCelltrion expects US President Donald Trump’s latest executive order aimed at lowering US prescription drug prices to levels in other reference countries to have a positive impact on the biosimilars i
Generics BulletinThe US Food and Drug Administration has deemed Celltrion’s Yuflyma (adalimumab-aaty) as interchangeable with the originator Humira. The interchangeability designation comes almost two years after Yufl
Pink SheetOn top of the recent major tariff announcement from US President Donald Trump, a ruling by South Korea’s Constitutional Court last week to go ahead with the removal of impeached former president Yoo
ScripOn top of the recent major tariff announcement from US President Donald Trump, a ruling by South Korea’s Constitutional Court last week to go ahead with the removal of impeached former president Yoo